Pitavastatin Inhibits Remnant Lipoprotein-Induced Macrophage Foam Cell Formation Through ApoB48 Receptor–Dependent Mechanism
Authors:
- Katsuyuki NakajimaKNKatsuyuki Nakajima
- Aye MAMAye M
- Kilpatrick EKEKilpatrick E
- Aburima AAAAburima A
- 1 February 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (2) , 424-429
Abstract
Objective— Atherogenic remnant lipoproteins (RLPs) are known to induce foam cell formation in macrophages in vitro and in vivo. We examined the involvement of apoB48 receptor (apoB48R), a novel receptor for RLPs, in that process in vitro and its potential regulation by pitavastatin. Methods and Results— THP-1 macrophages were incubated in the presence of RLPs (20 mg cholesterol/dL, 24 hours) isolated from hypertriglyceridemic subjects. RLPs significantly increased intracellular cholesterol ester (CE) and triglyceride (TG) contents (4.8-fold and 5.8-fold, respectively) in the macrophages. Transfection of THP-1 macrophages with short interfering RNA (siRNA) against apoB48R significantly inhibited RLP-induced TG accumulation by 44%. When THP-1 macrophages were pretreated with pitavastatin (5 μmol/L, 24 hours), the expression of apoB48R was significantly decreased and RLP-induced TG accumulation was reduced by 56%. ApoB48R siRNA also inhibited TG accumulation in THP-1 macrophage induced by β–very-low-density lipoprotein derived from apoE−/− mice by 58%, supporting the notion that apoB48R recognizes and takes-up RLPs in an apoE-independent manner. Conclusions— RLPs induce macrophage foam cell formation via apoB48R. Pitavastatin inhibits RLP-induced macrophage foam cell formation. The underlying mechanism involves, at least in part, inhibition of apoB48R-dependent mechanism. Our findings indicate a potential role of apoB48R in atherosclerosis.Keywords
This publication has 18 references indexed in Scilit:
- Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophagesBiochemical and Biophysical Research Communications, 2004
- Pitavastatin Downregulates Expression of the Macrophage Type B Scavenger Receptor, CD36Circulation, 2004
- Remnant Lipoprotein-Induced Smooth Muscle Cell Proliferation Involves Epidermal Growth Factor Receptor TransactivationCirculation, 2003
- PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptorJournal of Lipid Research, 2003
- Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart StudyAtherosclerosis, 2001
- Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gelsClinica Chimica Acta, 1993
- Intracellular disposition and metabolism of fluorescently-labled unmodified and modified oligouncleotides microijjected into mammalian cellsNucleic Acids Research, 1993
- Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.Proceedings of the National Academy of Sciences, 1989
- Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.Journal of Clinical Investigation, 1988
- Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal MacrophagesJournal of Clinical Investigation, 1982